Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw

Joanne M. Ajmo, Lauren A. Bailey, Matthew D. Howell, Lisa K. Cortez, Keith R. Pennypacker, Hina N. Mehta, Dave Morgan, Marcia N. Gordon, Paul E. Gottschall

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Aggregation of amyloid-β (Aβ) in the forebrain of Alzheimer's disease (AD) subjects may disturb the molecular organization of the extracellular microenvironment that modulates neural and synaptic plasticity. Proteoglycans are major components of this extracellular environment. To test the hypothesis that Aβ, or another amyloid precursor protein (APP) dependent mechanism modifies the accumulation and/or turnover of extracellular proteoglycans, we examined whether the expression and processing of brevican, an abundant extracellular, chondroitin sulfate (CS)-bearing proteoglycan, were altered in brains of Aβ-depositing transgenic mice (APPsw - APP gene bearing the Swedish mutation) as a model of AD. The molecular size of CS chains attached to brevican was smaller in hippocampal tissue from APPsw mice bearing Aβ deposits compared to non-transgenic mice, likely because of changes in the CS chains. Also, the abundance of the major proteolytic fragment of brevican was markedly diminished in extracts from several telencephalic regions of APPsw mice compared to non-transgenic mice, yet these immunoreactive fragments appeared to accumulate adjacent to the plaque edge. These results suggest that Aβ or APP exert inhibitory effects on proteolytic cleavage mechanisms responsible for synthesis and turnover of proteoglycans. As proteoglycans stabilize synaptic structure and inhibit molecular plasticity, defective brevican processing observed in Aβ-bearing mice and potentially end-stage human AD, may contribute to deficient neural plasticity.

Original languageEnglish (US)
Pages (from-to)784-795
Number of pages12
JournalJournal of Neurochemistry
Volume113
Issue number3
DOIs
StatePublished - May 1 2010

Fingerprint

Brevican
Bearings (structural)
Proteoglycans
Neuronal Plasticity
Chondroitin Sulfates
Amyloid beta-Protein Precursor
Plasticity
Processing
Alzheimer Disease
Chondroitin Sulfate Proteoglycans
Serum Amyloid A Protein
Telencephalon
Prosencephalon
Molecular Structure
Amyloid
Transgenic Mice
Brain
Deposits
Agglomeration
Genes

Keywords

  • ADAMTS
  • Alzheimer's disease
  • Amyloid β protein
  • Chondroitin sulfate
  • MMP
  • Proteoglycan

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw. / Ajmo, Joanne M.; Bailey, Lauren A.; Howell, Matthew D.; Cortez, Lisa K.; Pennypacker, Keith R.; Mehta, Hina N.; Morgan, Dave; Gordon, Marcia N.; Gottschall, Paul E.

In: Journal of Neurochemistry, Vol. 113, No. 3, 01.05.2010, p. 784-795.

Research output: Contribution to journalArticle

Ajmo, JM, Bailey, LA, Howell, MD, Cortez, LK, Pennypacker, KR, Mehta, HN, Morgan, D, Gordon, MN & Gottschall, PE 2010, 'Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw', Journal of Neurochemistry, vol. 113, no. 3, pp. 784-795. https://doi.org/10.1111/j.1471-4159.2010.06647.x
Ajmo, Joanne M. ; Bailey, Lauren A. ; Howell, Matthew D. ; Cortez, Lisa K. ; Pennypacker, Keith R. ; Mehta, Hina N. ; Morgan, Dave ; Gordon, Marcia N. ; Gottschall, Paul E. / Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw. In: Journal of Neurochemistry. 2010 ; Vol. 113, No. 3. pp. 784-795.
@article{9328c0383b7f433f8a453dc2a6b6281d,
title = "Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw",
abstract = "Aggregation of amyloid-β (Aβ) in the forebrain of Alzheimer's disease (AD) subjects may disturb the molecular organization of the extracellular microenvironment that modulates neural and synaptic plasticity. Proteoglycans are major components of this extracellular environment. To test the hypothesis that Aβ, or another amyloid precursor protein (APP) dependent mechanism modifies the accumulation and/or turnover of extracellular proteoglycans, we examined whether the expression and processing of brevican, an abundant extracellular, chondroitin sulfate (CS)-bearing proteoglycan, were altered in brains of Aβ-depositing transgenic mice (APPsw - APP gene bearing the Swedish mutation) as a model of AD. The molecular size of CS chains attached to brevican was smaller in hippocampal tissue from APPsw mice bearing Aβ deposits compared to non-transgenic mice, likely because of changes in the CS chains. Also, the abundance of the major proteolytic fragment of brevican was markedly diminished in extracts from several telencephalic regions of APPsw mice compared to non-transgenic mice, yet these immunoreactive fragments appeared to accumulate adjacent to the plaque edge. These results suggest that Aβ or APP exert inhibitory effects on proteolytic cleavage mechanisms responsible for synthesis and turnover of proteoglycans. As proteoglycans stabilize synaptic structure and inhibit molecular plasticity, defective brevican processing observed in Aβ-bearing mice and potentially end-stage human AD, may contribute to deficient neural plasticity.",
keywords = "ADAMTS, Alzheimer's disease, Amyloid β protein, Chondroitin sulfate, MMP, Proteoglycan",
author = "Ajmo, {Joanne M.} and Bailey, {Lauren A.} and Howell, {Matthew D.} and Cortez, {Lisa K.} and Pennypacker, {Keith R.} and Mehta, {Hina N.} and Dave Morgan and Gordon, {Marcia N.} and Gottschall, {Paul E.}",
year = "2010",
month = "5",
day = "1",
doi = "10.1111/j.1471-4159.2010.06647.x",
language = "English (US)",
volume = "113",
pages = "784--795",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw

AU - Ajmo, Joanne M.

AU - Bailey, Lauren A.

AU - Howell, Matthew D.

AU - Cortez, Lisa K.

AU - Pennypacker, Keith R.

AU - Mehta, Hina N.

AU - Morgan, Dave

AU - Gordon, Marcia N.

AU - Gottschall, Paul E.

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Aggregation of amyloid-β (Aβ) in the forebrain of Alzheimer's disease (AD) subjects may disturb the molecular organization of the extracellular microenvironment that modulates neural and synaptic plasticity. Proteoglycans are major components of this extracellular environment. To test the hypothesis that Aβ, or another amyloid precursor protein (APP) dependent mechanism modifies the accumulation and/or turnover of extracellular proteoglycans, we examined whether the expression and processing of brevican, an abundant extracellular, chondroitin sulfate (CS)-bearing proteoglycan, were altered in brains of Aβ-depositing transgenic mice (APPsw - APP gene bearing the Swedish mutation) as a model of AD. The molecular size of CS chains attached to brevican was smaller in hippocampal tissue from APPsw mice bearing Aβ deposits compared to non-transgenic mice, likely because of changes in the CS chains. Also, the abundance of the major proteolytic fragment of brevican was markedly diminished in extracts from several telencephalic regions of APPsw mice compared to non-transgenic mice, yet these immunoreactive fragments appeared to accumulate adjacent to the plaque edge. These results suggest that Aβ or APP exert inhibitory effects on proteolytic cleavage mechanisms responsible for synthesis and turnover of proteoglycans. As proteoglycans stabilize synaptic structure and inhibit molecular plasticity, defective brevican processing observed in Aβ-bearing mice and potentially end-stage human AD, may contribute to deficient neural plasticity.

AB - Aggregation of amyloid-β (Aβ) in the forebrain of Alzheimer's disease (AD) subjects may disturb the molecular organization of the extracellular microenvironment that modulates neural and synaptic plasticity. Proteoglycans are major components of this extracellular environment. To test the hypothesis that Aβ, or another amyloid precursor protein (APP) dependent mechanism modifies the accumulation and/or turnover of extracellular proteoglycans, we examined whether the expression and processing of brevican, an abundant extracellular, chondroitin sulfate (CS)-bearing proteoglycan, were altered in brains of Aβ-depositing transgenic mice (APPsw - APP gene bearing the Swedish mutation) as a model of AD. The molecular size of CS chains attached to brevican was smaller in hippocampal tissue from APPsw mice bearing Aβ deposits compared to non-transgenic mice, likely because of changes in the CS chains. Also, the abundance of the major proteolytic fragment of brevican was markedly diminished in extracts from several telencephalic regions of APPsw mice compared to non-transgenic mice, yet these immunoreactive fragments appeared to accumulate adjacent to the plaque edge. These results suggest that Aβ or APP exert inhibitory effects on proteolytic cleavage mechanisms responsible for synthesis and turnover of proteoglycans. As proteoglycans stabilize synaptic structure and inhibit molecular plasticity, defective brevican processing observed in Aβ-bearing mice and potentially end-stage human AD, may contribute to deficient neural plasticity.

KW - ADAMTS

KW - Alzheimer's disease

KW - Amyloid β protein

KW - Chondroitin sulfate

KW - MMP

KW - Proteoglycan

UR - http://www.scopus.com/inward/record.url?scp=77950679263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950679263&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2010.06647.x

DO - 10.1111/j.1471-4159.2010.06647.x

M3 - Article

C2 - 20180882

AN - SCOPUS:77950679263

VL - 113

SP - 784

EP - 795

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 3

ER -